10-K Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 FY 2023

Filing Information

Form Type	10-K
Accession Number	`0001558370-24-002730`
Period End Date	20231231
Filing Date	20240307
Fiscal Year	2023
Fiscal Period	FY
XBRL Instance	bpth-20231231x10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 53 Income Statement 23 Cash Flow Statement 35 Stockholders Equity 13

Balance Sheet 53 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$10.38M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$1.05M	USD	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$632.00K	USD	Point-in-time
Prepaid drug product	`PrepaidExpenseCurrent`	$3.59M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.36M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.64M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.04M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$15.62M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	398,000.00	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	618,000.00	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	398,000.00	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.12M	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$1.12M	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	618,000.00	shares	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$1.04M	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$962.00K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$158.00K	USD	Point-in-time
Fixed assets, net	`PropertyPlantAndEquipmentNet`	$76.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$198.00K	USD	Point-in-time
Right of use operating assets	`OperatingLeaseRightOfUseAsset`	$102.00K	USD	Point-in-time
Total Assets	`Assets`	$3.22M	USD	Point-in-time
Total Assets	`Assets`	$15.97M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$457.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$667.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$909.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.35M	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$103.00K	USD	Point-in-time
Current portion of lease liabilities	`OperatingLeaseLiabilityCurrent`	$108.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.68M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.91M	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$863.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$113.00K	USD	Point-in-time
Noncurrent lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$10.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$2.78M	USD	Point-in-time
Total Liabilities	`Liabilities`	$1.80M	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 618 and 398 shares issued and outstanding, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 618 and 398 shares issued and outstanding, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$108.05M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$105.70M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-107.61M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-91.53M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$441.00K	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$14.17M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$15.97M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$3.22M	USD	Point-in-time

Income Statement 23 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$9.16M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$11.61M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$4.74M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$4.24M	USD	Annual
Total operating expenses	`OperatingExpenses`	$15.84M	USD	Annual
Total operating expenses	`OperatingExpenses`	$13.90M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-15.84M	USD	Annual
Net operating loss	`OperatingIncomeLoss`	$-13.90M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$33.00K	USD	Annual
Interest income	`InvestmentIncomeInterest`	$36.00K	USD	Annual
Change in fair value of warrant liability	`PeriodChangesInFairValueOfWarrantLiability`	$271.00K	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$33.00K	USD	Annual
Total other income	`NonoperatingIncomeExpense`	$-235.00K	USD	Annual
Net loss	`NetIncomeLoss`	$-13.87M	USD	Annual
Net loss	`NetIncomeLoss`	$-16.08M	USD	Annual
Net loss per share, basic	`EarningsPerShareBasic`	$-33.63	USD	Annual
Net loss per share, basic	`EarningsPerShareBasic`	$-38.12	USD	Annual
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	478,000.00	shares	Annual
Weighted average number of common shares outstanding, basic	`WeightedAverageNumberOfSharesOutstandingBasic`	364,000.00	shares	Annual
Net loss per share, diluted	`EarningsPerShareDiluted`	$-33.63	USD	Annual
Net loss per share, diluted	`EarningsPerShareDiluted`	$-38.12	USD	Annual
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	364,000.00	shares	Annual
Weighted average number of common shares outstanding, diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	478,000.00	shares	Annual

Cash Flow Statement 35 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-16.08M	USD	Annual
Net loss	`ProfitLoss`	$-13.87M	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$851.00K	USD	Annual
Stock-based compensation	`ShareBasedCompensation`	$734.00K	USD	Annual
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$90.00K	USD	Annual
Amortization of right of use assets	`OperatingLeaseRightOfUseAssetAmortizationExpense`	$96.00K	USD	Annual
Depreciation	`Depreciation`	$82.00K	USD	Annual
Depreciation	`Depreciation`	$88.00K	USD	Annual
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$271.00K	USD	Annual
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$-2.96M	USD	Annual
Prepaid drug product	`IncreaseDecreaseInPrepaidExpense`	$3.06M	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-199.00K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-286.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$227.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$700.00K	USD	Annual
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-108.00K	USD	Annual
Lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-99.00K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-11.54M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-15.10M	USD	Annual
Purchases of furniture, fixtures & equipment	`PaymentsToAcquireFurnitureAndFixtures`	$21.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-21.00K	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.68M	USD	Annual
Net proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$1.73M	USD	Annual
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$526.00K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.20M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.73M	USD	Annual
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-9.33M	USD	Annual
Net decrease in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-13.39M	USD	Annual
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.38M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.77M	USD	Point-in-time
Cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$10.38M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$23.77M	USD	Point-in-time
Cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.05M	USD	Point-in-time
Right of use asset recognized in exchange for lease obligation	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$85.00K	USD	Annual

Stockholders Equity 13 line items

Line Item	Tag	Value	Unit	Period
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$441.00K	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.46M	USD	Point-in-time
Stockholders' equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.17M	USD	Point-in-time
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$491.00K	USD	Annual
Issuance of common stock, net of fees	`StockIssuedDuringPeriodValueNewIssues`	$1.73M	USD	Annual
Exercise of warrants, net of fees	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$1.12M	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$851.00K	USD	Annual
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$734.00K	USD	Annual
Net Income (Loss)	`NetIncomeLoss`	$-13.87M	USD	Annual
Net Income (Loss)	`NetIncomeLoss`	$-16.08M	USD	Annual
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$441.00K	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$25.46M	USD	Point-in-time
Stockholders' equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.17M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.